Tag Archives: national cancer institute

ATCC Lands NCI Contract to Build Cancer Models Distribution Infrastructure

ATCC has been awarded a contract by the National Cancer Institute to develop a technology infrastructure to support the production, intake and distribution of cancer cell lines for the international research community. The company said Wednesday it will build the infrastructure for the Human Cancer Models Initiative that aims to generate as many as 1,000 new cancer …

Read More »

Leidos Subcontracts ATCC for NCI Biospecimen Repository Operations Support

ATCC has received a potential seven-year, $32 million subcontract from a Leidos subsidiary to manage a National Cancer Institute biospecimen repository in Frederick, Maryland. ATCC said Tuesday its team will store and distribute biospecimens to basic and clinical investigators who support cancer and infectious disease research efforts as well as manage operational costs and logistics at …

Read More »

PapGene Aims to Commercialize Bladder Cancer Surveillance Test With NIH Contract Funds

Baltimore, Maryland-based biotechnology company PapGene has secured a potential $2.2 million contract from a National Institutes of Health center to study and commercialize a recurrent bladder cancer surveillance test. PapGene said Tuesday it will receive $299,824 funds from NIH’s National Cancer Institute under the first phase of the Fast-Track Small Business Innovation Research contract to demonstrate the …

Read More »

SRI Int’l to Support Anti-Cancer Vaccine Studies for NIH Center

SRI International will carry out pre-clinical studies on compounds and vaccines to determine if they can act as preventive agents against cancer under a $19.8 million contract with a National Institutes of Health center. The company said Thursday its biosciences division will work to examine the effectiveness of experimental vaccines and test biomarkers in an effort to …

Read More »

SRI Awarded National Cancer Institute Drug Support Contract; Toufan Parman Comments

SRI International will provide preclinical treatment development support for the National Cancer Institute’s Prevent Cancer Drug Development Program under a potential $9 million contract. NCI’s Prevent initiative aims to advance the development of biomarkers and drug candidates designed to prevent cancer and transition them from preclinical phase to clinical trials, …

Read More »

Kamal Narang: SRA to Support Genomic Data Exchange, Bioinformatics R&D Efforts

SRA International has joined an international data-sharing coalition that seeks to develop a common framework for organizations to exchange genomic information for research and clinical applications. SRA said Tuesday that Global Alliance for Genomics and Health members come from the information technology, healthcare, research, life sciences and pharmaceutical sectors. “We’re …

Read More »

Harris Corp. to Provide Cancer Center with Healthcare Dashboards; Vishal Agrawal Comments

Harris Corp. has been selected by Cancer center City of Hope to provide healthcare business intelligence dashboards to enhance the hospital’s strategic plan and improve performance. The Melbourne,Fl.-based company will implement its business intelligence practice variation dashboards to help City of Hope’s physicians, hospital management and coding professionals identify room for …

Read More »

SAIC Subsidiary Helping Move Natl Cancer Institute Software Projects To Open Source; Luis Ibanez Comments

A Science Applications International Corp. subsidiary and an open source software developer have won a subcontract to move National Cancer Institute-sponsored software projects into an open source environment. SAIC-Frederick and Kitware will aim to develop a set of procedures for migrating projects from subversion repositories hosted at the NCI to …

Read More »

Harris Earns Recompete Contract for NCI Cancer Research

Harris Corp. has won an award to provide the National Cancer Institute‘s Center for Cancer Research with clinical data management services for the intramural clinical trials program. The company will provide the work under a $37 million recompete contract, which includes one base year and four one-year options. Harris has supported the clinical trials …

Read More »